These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 8579245)
1. [Molecular biology of infections caused by HIV and other hepatotropic viruses]. Schüller Pérez A An R Acad Nac Med (Madr); 1995; 112(3):585-613; discussion 614-5. PubMed ID: 8579245 [No Abstract] [Full Text] [Related]
2. Evidence of multiple hepatitis virus infections in autopsied materials of intravenous drug addicts. Schleicher S; Schieffer M; Jürgens S; Wehner HD; Flehmig B Ig Sanita Pubbl; 2005; 61(5):435-50. PubMed ID: 17214028 [TBL] [Abstract][Full Text] [Related]
3. [Risk of infection in a hospital environment]. Perrelli G; Perrelli F; Marconcini M G Ital Med Lav Ergon; 1998; 20(1):15-23. PubMed ID: 9546097 [TBL] [Abstract][Full Text] [Related]
4. [The role of the Ministry of Health in the prevention of diseases caused by blood transfusion]. Wolpert Barraza E; Córdova MS; Robles Díaz G; Reyes López PA Gac Med Mex; 1994; 130(6):412-24. PubMed ID: 7557054 [No Abstract] [Full Text] [Related]
5. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission. Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605 [TBL] [Abstract][Full Text] [Related]
6. HIV and hep. B and C code of practice. Aust Nurses J; 1992 Jun; 21(11):25-6. PubMed ID: 1530513 [No Abstract] [Full Text] [Related]
7. Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates. Kane A; Lloyd J; Zaffran M; Simonsen L; Kane M Bull World Health Organ; 1999; 77(10):801-7. PubMed ID: 10593027 [TBL] [Abstract][Full Text] [Related]
8. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa. Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474 [TBL] [Abstract][Full Text] [Related]
9. Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus. Seed CR; Kiely P; Keller AJ Intern Med J; 2005 Oct; 35(10):592-8. PubMed ID: 16207258 [TBL] [Abstract][Full Text] [Related]
10. Transfusion-dependent thalassemia: viral complications (epidemiology and follow-up). de Montalembert M; Girot R; Mattlinger B; Lefrère JJ Semin Hematol; 1995 Oct; 32(4):280-7. PubMed ID: 8560285 [No Abstract] [Full Text] [Related]
11. Viral hepatitis. What have we learned about risk factors and transmission? Becherer PR Postgrad Med; 1995 Jul; 98(1):65-8, 71-4. PubMed ID: 7603948 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of HIV, hepatitis B, C and G virus infections among injecting drug users on methadone maintenance treatment in Maribor. Baklan Z; Gorisek JR; Poljak M; Pisec A Wien Klin Wochenschr; 2004; 116 Suppl 2():5-7. PubMed ID: 15506302 [TBL] [Abstract][Full Text] [Related]
13. The significance of non-A, non-B hepatitis, cytomegalovirus and the acquired immune deficiency syndrome in transfusion practice. Bayer WL; Tegtmeier GE; Barbara JA Clin Haematol; 1984 Feb; 13(1):253-69. PubMed ID: 6327132 [No Abstract] [Full Text] [Related]
14. National Advisory Committee on Immunization (NACI). Statement on safety of immune globulin preparations. Can Dis Wkly Rep; 1988 Jun; 14(24):103. PubMed ID: 3149550 [No Abstract] [Full Text] [Related]
15. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey. Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR; Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163 [TBL] [Abstract][Full Text] [Related]
16. Early acquisition of TT virus (TTV) in an area endemic for TTV infection. Davidson F; MacDonald D; Mokili JL; Prescott LE; Graham S; Simmonds P J Infect Dis; 1999 May; 179(5):1070-6. PubMed ID: 10191206 [TBL] [Abstract][Full Text] [Related]
17. [Prevalence of HIV and hepatitis B and C among drug addicts in the city of Copenhagen]. Fuglsang T; Fouchard JR; Ege PP Ugeskr Laeger; 2000 Jul; 162(27):3860-4. PubMed ID: 10920701 [TBL] [Abstract][Full Text] [Related]
18. Prevalence and risk factors of hepatitis C virus, hepatitis B virus, and human immunodeficiency virus in multiply transfused recipients in Mexico. Calderón GM; González-Velázquez F; González-Bonilla CR; Novelo-Garza B; Terrazas JJ; Martínez-Rodríguez ML; Cortés-Márquez SR; Blanco-Flores JP; Rodríguez-Rodríguez A; Del Campo MA; Cortés-Gómez R; Mejía-Bocanegra MG Transfusion; 2009 Oct; 49(10):2200-7. PubMed ID: 19538543 [TBL] [Abstract][Full Text] [Related]
19. Epidemiology of hepatitis B, C, and E viruses and human immunodeficiency virus infections in Tahuna, Sangihe-Talaud Archipelago, Indonesia. Achwan WA; Muttaqin Z; Zakaria E; Depamede SA; Mulyanto ; Sumoharjo S; Tsuda F; Takahashi K; Abe N; Mishiro S Intervirology; 2007; 50(6):408-11. PubMed ID: 18185013 [TBL] [Abstract][Full Text] [Related]
20. Update: transmission of HIV infection during an invasive dental procedure: United States. Can Dis Wkly Rep; 1991 Jan; 17(4):17-22. PubMed ID: 2009571 [No Abstract] [Full Text] [Related] [Next] [New Search]